Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction

Publisher： Karger

E-ISSN： 1421-9751|137|2|121-125

ISSN： 0008-6312

Source： Cardiology, Vol.137, Iss.2, 2017-04, pp. : 121-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin-Converting Enzyme Inhibitor Use in Elderly Patients Hospitalized with Heart Failure and Left Ventricular Systolic Dysfunction

By  

Cardiology, Vol. 103, Iss. 1, 2004-11 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Gene Polymorphism on the Left-Ventricular Function and Mass in Patients with Acromegaly

By  

Cardiology, Vol. 92, Iss. 4, 2000-04 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 29-41

John Wiley & Sons Inc

Access to resources Recommend Favorite

From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors

By  

Cardiology, Vol. 117, Iss. 3, 2010-11 ,pp. : 163-173

Karger

Access to resources Recommend Favorite

Reducing the Risk of Recurrences after Pulmonary Vein Isolation: What Is the Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers?

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 11-13

Karger

Access to resources Recommend Favorite